AIM
ALNY icon

Assured Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Assured Investment Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,826
Closed -$232K – 1159
2017
Q4 		$232K Buy
+1,826
New +$229K ﹤0.01% 489
2016
Q3 		– Sell
-9,608
Closed -$533K – 601
2016
Q2 		$533K Buy
9,608
+6,429
+202% +$405K 0.01% 397
2016
Q1 		$200K Buy
3,179
+1,500
+89% +$99.7K ﹤0.01% 486
2015
Q4 		$158K Sell
1,679
-3
-0.2% -$278 ﹤0.01% 498
2015
Q3 		$135K Buy
1,682
+267
+19% +$29.7K ﹤0.01% 533
2015
Q2 		$170K Buy
+1,415
New +$169K ﹤0.01% 512

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return